ArriVent BioPharma, Inc. Common Stock (AVBP)
Filed: 3 Feb 25, 7:05am
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use of our report dated March 28, 2024, with respect to the financial statements of ArriVent BioPharma, Inc., incorporated herein by reference and to the reference to our firm under the heading “Experts” in the prospectus.
| /s/ KPMG LLP |
Philadelphia, Pennsylvania
February 3, 2025